Mode
Text Size
Log in / Sign up
N/A N=60 Randomized Double-blind Treatment

Clinical Validation of DACP Digital Design

Refractive Errors

Enrolled (actual)
60
Serious AEs
0.0%
Results posted
Jun 2019
Primary outcome: Primary: Distance Visual Acuity (VA) (logMAR, OU) — -0.11; -0.12 logMAR

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Nelfilcon A digital contact lenses (Device); Nelfilcon A contact lenses (Device)
Age
Adult · 18+ yrs
Sex
All
Sponsor
Alcon Research
Primary completion
Aug 2018

Outcome Measures

OutcomeResultp-value
PRIMARY
Distance Visual Acuity (VA) (logMAR, OU)
-0.11; -0.12
SECONDARY
Overall Vision
8.8; 8.9

Summary

The purpose of this study is to evaluate the visual performance of DAILIES® AquaComfort Plus® (DACP) Digital lenses by assessing distance visual acuity (VA) as compared to DACP sphere contact lenses after one week of wear.

Eligibility Criteria

Inclusion Criteria

  • Willing and able to sign an IRB/IEC approved Informed Consent form;
  • Current wearer of DACP spherical contact lenses (at least 2 months in current correction), with a minimum wearing time of 5 days per week and 8 hours per day;
  • Experiencing symptoms of eye strain from using technology;
  • Willing to wear study lenses each day;
  • Possess spectacles that provide a corrected visual acuity of 20/40 or better in both eyes (OU) and be willing to wear them (as needed);
  • Willing to NOT use rewetting/lubricating drops at any time during the study;
  • Currently using digital devices (computer, tablet, and/or smart phone) for a minimum of 5 days per week and 4 hours per day;
  • Willing to NOT use any near aid (e.g. reading glasses) at any time during the study.

Exclusion Criteria

  • Conditions, use of medications, injury, or surgery, as specified in the protocol;
  • Wearing habitual contact lenses in an extended wear modality (routinely sleeping in lenses for at least 1 night per week) over the last 3 months prior to enrollment;
  • Monocular (only one eye with functional vision);
  • Pregnant.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03567005). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search